CAR T-Cell Therapy Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2032

Global CAR T-Cell Therapy Market: By indication (Leukemia, Lymphoma, and Myeloma); Source (Autologous and Allogenic); Type of Therapy (Monotherapy and Combination Therapy); Product (ABECMA, Breyanzi, Carvykti, Kymriah, Tecartus, and Yescarta); Administration Setting (Inpatient and Outpatient); Region—Market Forecast and Analysis for 2024-2032

The global CAR T-Cell Therapy Market is projected to reach more than USD 22.2 billion by 2032 from USD 2.1 billion in 2023, growing at a CAGR of 30% from 2024-2032. Read More

We Are Trusted By These Great Companies!

• Published On: 02-Mar-2024  |  Format:  |  Report ID: AA0324792